Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 500 of 1294 entries
View as:

A Research Study of How Overdosing of a New Once Weekly Medicine NNC0148-0287 C (Insulin 287) Influences the Blood Sugar Level in People With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT03945656 Org: User:
Start: 05/07/19 End: 09/27/21 Due: 09/27/22

Prandial Orientated Biphasic Insulin Aspart 30 Therapy - the Physiological Premix Insulin Therapy for Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01536652 Org: User:
Start: 01/31/06 End: 11/30/06 Due: 11/30/07

The Effect of Insulin Detemir in Combination With Liraglutide and Metformin Compared to Liraglutide and Metformin in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00856986 Org: User:
Start: 03/31/09 End: 11/30/10 Due: 11/30/11

SELECT-LIFE: A Research Study Looking at Long-term Effects of Semaglutide in People Who Took Part in the SELECT Cardiovascular Outcomes Trial

Phase: N/A Priority: Normal
NCT ID: NCT04972721 Org: User:
Start: 09/01/23 End: 11/30/33 Due: 11/30/34

Effect of Insulin Detemir on Blood Glucose Control in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00383877 Org: User:
Start: 09/30/06 End: 08/31/07 Due: 08/31/08

Comparison of NN5401 Versus Biphasic Insulin Aspart 30 on a Twice Daily Regimen in Subjects With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT00842361 Org: User:
Start: 01/31/09 End: 06/30/09 Due: 06/30/10

A Research Study of How Semaglutide Works in People With Disease Affecting the Heart and/or Blood Vessels and Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT04032197 Org: User:
Start: 08/12/19 End: 06/06/23 Due: 06/06/24

Efficacy and Safety of Biphasic Insulin Aspart 30 FlexPen® in Insulin Naive Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00600366 Org: User:
Start: 03/31/04 End: 01/31/05 Due: 01/31/06

Efficacy and the Safety of Insulin Detemir in Subjects With Insulin Requiring Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00604344 Org: User:
Start: 04/30/03 End: 03/31/05 Due: 03/31/06

Observational Study of Biphasic Insulin Aspart 30 Alone or in Combination With Oral Hypoglycaemic Agents in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01536600 Org: User:
Start: 09/30/04 End: 12/31/06 Due: 12/31/07

Evaluation of Levemir® for the Treatment of Type 1 and 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00655044 Org: User:
Start: 05/31/07 End: 01/31/08 Due: 01/31/09

Safety and Preliminary Efficacy of Activated Recombinant Human Factor VII for Preventing Early Hematoma Growth in Acute Intracerebral Haemorrhage

Phase: N/A Priority: Normal
NCT ID: NCT01563445 Org: User:
Start: 11/30/01 End: 03/31/03 Due: 03/31/04

Single Dose Pharmacokinetics of Repaglinide, Metformin and Combination Tablet in Fed Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01490658 Org: User:
Start: 06/30/06 End: 08/31/06 Due: 08/31/07

Comparing the Efficacy and Safety of Biphasic Insulin Aspart 30 and Biphasic Human Insulin 30 on Blood Sugar Control in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00807092 Org: User:
Start: 12/31/08 End: 10/31/09 Due: 10/31/10

Comparison of Two NN5401 Formulations Versus Insulin Glargine, All in Combination With Metformin in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00614055 Org: User:
Start: 01/31/08 End: 07/31/08 Due: 07/31/09

A Study to Compare Insulin Intensification of Biphasic Insulin Aspart 30 and Insulin Analogues (Insulin Glargine and Insulin Aspart) in Insulin naïve Type 2 Diabetic Patients

Phase: N/A Priority: Normal
NCT ID: NCT02453685 Org: User:
Start: 08/31/15 End: 09/20/16 Due: 09/20/17

Cities for Better Health Childhood Obesity Prevention Initiative

Phase: N/A Priority: Normal
NCT ID: NCT06855563 Org: User:
Start: 04/30/25 End: 12/31/27 Due: 12/31/28

Comparison of Pharmacodynamics and Pharmacokinetics of Biphasic Insulin Aspart 50 to Biphasic Insulin Aspart 70 in Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00612599 Org: User:
Start: 09/30/03 End: 06/30/04 Due: 06/30/05

Efficacy and Safety of FIAsp in a Basal-bolus Regimen Versus Basal Insulin Therapy, Both in Combination With Metformin in Adult Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01850615 Org: User:
Start: 09/23/13 End: 11/17/14 Due: 11/17/15

Investigation of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Dosing of NNC0174-0833 in Subjects With Obesity or Overweight

Phase: N/A Priority: Normal
NCT ID: NCT02958085 Org: User:
Start: 11/04/16 End: 01/24/18 Due: 01/24/19

A Clinical Proof-of-principle Trial in Adult Subjects With Newly Diagnosed Type 1 Diabetes Mellitus Investigating the Effect of NNC0114-0006 and Liraglutide on Preservation of Beta-cell Function

Phase: N/A Priority: Normal
NCT ID: NCT02443155 Org: User:
Start: 11/10/15 End: 02/27/19 Due: 02/27/20

Pharmacokinetics of Biphasic Insulin Aspart 30 and 70 in Subjects With Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01524809 Org: User:
Start: 01/31/01 End: 06/30/01 Due: 06/30/02

A Trial Investigating the Pharmacokinetics and Pharmacodynamics of rFVIIa in Patients With Haemophilia A or B With or Without Inhibitors

Phase: N/A Priority: Normal
NCT ID: NCT01949792 Org: User:
Start: 09/30/13 End: 11/30/13 Due: 11/30/14

A First Human Dose Trial Investigating Safety, Tolerability and Pharmacokinetics for Single Doses of NNC9204-1177 in Subjects Being Overweight or With Obesity.

Phase: N/A Priority: Normal
NCT ID: NCT02941042 Org: User:
Start: 10/10/16 End: 09/30/17 Due: 09/30/18

Comparison of Insulin Aspart Produced by the NN2000 Process to the Current Process in Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00604656 Org: User:
Start: 05/05/03 End: 01/29/04 Due: 01/29/05